Deborah Knobelman Kronos Bio, Inc. (KRON) insider trading activity

Deborah Knobelman is Chief Financial Officer of Kronos Bio, Inc.. Currently has a direct ownership of 164,260 shares of KRON, which is worth approximately $156,047. The most recent transaction as insider was on Jun 03, 2024, when has been sold 164,260 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 164K

0% 3M change

n/a 12M change

Total Value Held $156,047

DEBORAH KNOBELMAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 03 2024	BUY Grant, award, or other acquisition	-	164,260 Added 50.0%	164,260 Common Stock

Also insider at

SNTI

Senti Biosciences, Inc. Healthcare

Chief Financial Officer